COL16A1 and central nervous system cancer: COL16A1 has been found to reduce glioma invasiveness [63], and while we could not find a study that associated it with survival, an automatized survival analysis reported by The Human Protein Atlas suggests a link to differential survival in glioma (https://www.proteinatlas.org/ENSG00000084636-COL16A1/pathology; accessed on 2 July 2021).